A Nutra Pharma befolyásoló és közösségi média kampányt hirdet a Nyloxin és a Pet Pain-Away érdekében

Nutra Pharma is announcing their newest marketing plans for their over-the-counter pain relievers will utilize influencers, celebrities and athletes on social media platforms

Plantation, Florida, 24. május 2021. – McapMediaWire  - Nutra Pharma Corporation (OTC Pink: NPHC), egy biotechnológiai cég marketingje Nyloxin®, Pet Pain-Away és a Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today their plans for expanding the marketing of their over-the-counter pain relievers and anti-inflammatory products by working with influencers on several social media platforms. These will include celebrities as well as professional and Olympic athletes that have benefitted from Nutra Pharma’s products.

“We have life-changing products that need much wider attention,” commented Nina Goldstein, Marketing Manager of Nutra Pharma. “While we’ve seen some real growth in retail and on-line sales of our products over the past year, we are still struggling to get brand recognition and substantial acceptance of these exceptional products,” she continued. “By working with social media influencers that are already using these products, we can reach an incredibly large audience of new potential customers. As these sales grow, it will go hand in hand with our rollout into broader retail sales across the United States and internationally,” she concluded.

A Nyloxin® egy biztonságos, nem kábító és nem okoz függőséget okozó homeopátiás fájdalomcsillapító a fájdalom csillapítására a kognitív funkciók károsodása nélkül. A Nyloxin® fájdalomcsillapítóként és gyulladáscsökkentőként számos előnnyel jár. A Nyloxin® jól meghatározott biztonsági profillal rendelkezik. Az 1930-as évek eleje óta a hatóanyagot (API), az ázsiai kobramérget több mint 46 humán klinikai vizsgálatban tanulmányozták. A nyloxin szájspray formájában kapható szisztémás fájdalom kezelésére és helyi gélként a fájdalom célzott kezelésére.

Pet Pain-Away™ is a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever aimed at treating moderate to severe chronic pain in companion animals. It is specifically indicated to treat pain from hip dysplasia, arthritis pain, joint pain, and general chronic pain in cats and dogs. Specialized proteins in Pet Pain-Away block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off.

A cég jelenleg a Nyloxint forgalmazza www.Nyloxin.com valamint az Amazon piacterük a címen www.Amazon.com/nyloxin. Pet Pain-Away is being marketed through www.PetPainAway.com. Equine Pain-Away is being marketed through www.EquinePainAway.com, Míg a Luxus láb keresztül kerül forgalomba www.LuxuryFeet.com.

A Nutra Pharma Corp.-ról

A Nutra Pharma Corporation biotechnológiai vállalatként működik, amely neurológiai rendellenességek, rák, autoimmun és fertőző betegségek, köztük a szklerózis multiplex (MS) és a humán immunhiány vírus (HIV) kezelésére szolgáló gyógyszerészeti termékek és technológiák beszerzésére, engedélyezésére és kereskedelmi forgalomba hozatalára szakosodott. és a Fájdalom. Ezen túlmenően a Társaság Nyloxin®, Equine Pain-Away™, Pet Pain-Away™ és Luxury Feet™ márkanév alatt fájdalomcsillapító gyógyszereket is forgalmaz eladásra. A Nutra Pharma-val kapcsolatos további információkért látogasson el:

http://www.NutraPharma.com or

http://www.nyloxin.com

http://www.petpainaway.com

http://www.equinepainaway.com

http://www.luxuryfeet.com

SEC Jogi nyilatkozat

This press release contains forward-looking statements. The words or phrases “would be,” “will allow,” “intends to,” “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimate,” “project,” or similar expressions are intended to identify “forward-looking statements.” Actual results could differ materially from those projected in Nutra Pharma’s (“the Company”) business plan. The influencer campaign for the Company’s products should not be construed as an indication in any way whatsoever of the future value of the Company’s common stock or its financial value. The Company’s filings may be accessed at the SEC’s Edgar system at www.sec.gov.  Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

Source: https://otcprwire.com/nutra-pharma-announces-influencer-and-social-media-campaign-for-nyloxin-and-pet-pain-away/